GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » WPD Pharmaceuticals Inc (XCNQ:WBIO) » Definitions » PEG Ratio

WPD Pharmaceuticals (XCNQ:WBIO) PEG Ratio : N/A (As of Apr. 25, 2025)


View and export this data going back to 2008. Start your Free Trial

What is WPD Pharmaceuticals PEG Ratio?

PE Ratio without NRI / 5-Year EBITDA Growth Rate*

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, WPD Pharmaceuticals's PE Ratio without NRI is 0.00. WPD Pharmaceuticals's 5-Year EBITDA growth rate is 0.00%. Therefore, WPD Pharmaceuticals's PEG Ratio for today is N/A.

* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


The historical rank and industry rank for WPD Pharmaceuticals's PEG Ratio or its related term are showing as below:



XCNQ:WBIO's PEG Ratio is not ranked *
in the Biotechnology industry.
Industry Median: 1.44
* Ranked among companies with meaningful PEG Ratio only.

Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.


WPD Pharmaceuticals PEG Ratio Historical Data

The historical data trend for WPD Pharmaceuticals's PEG Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

WPD Pharmaceuticals PEG Ratio Chart

WPD Pharmaceuticals Annual Data
Trend Jan13 Jan14 Jan15 Jan16 Jan17 Jan18 Jan19 Dec20 Dec22 Dec23
PEG Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

WPD Pharmaceuticals Quarterly Data
Jul19 Oct19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
PEG Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of WPD Pharmaceuticals's PEG Ratio

For the Biotechnology subindustry, WPD Pharmaceuticals's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


WPD Pharmaceuticals's PEG Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, WPD Pharmaceuticals's PEG Ratio distribution charts can be found below:

* The bar in red indicates where WPD Pharmaceuticals's PEG Ratio falls into.


;
;

WPD Pharmaceuticals PEG Ratio Calculation

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The ratio we use is the 5-Year EBITDA growth rate.

WPD Pharmaceuticals's PEG Ratio for today is calculated as

PEG Ratio=PE Ratio without NRI/5-Year EBITDA Growth Rate*
=/0.00
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


WPD Pharmaceuticals  (XCNQ:WBIO) PEG Ratio Explanation

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.


WPD Pharmaceuticals PEG Ratio Related Terms

Thank you for viewing the detailed overview of WPD Pharmaceuticals's PEG Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


WPD Pharmaceuticals Business Description

Traded in Other Exchanges
Address
700-595 Burrard Street, Suite 401, Vancouver, BC, CAN, V7X 1S8
WPD Pharmaceuticals Inc is a biotechnology research and development company. It focuses on oncology, virology, research, and development of medicinal products involving biological compounds and small molecules.
Executives
Constantine Carmichel Director

WPD Pharmaceuticals Headlines

No Headlines